Lupus And Its Complications: Impact on Quality of Life
- Lupus Trust India
- 4 days ago
- 5 min read
By Dr. Chethana D, Rheumatologist
What is Lupus?
Lupus / SLE (systemic lupus erythematosus), is a chronic autoimmune disease in which the body’s immune system mistakenly attacks its own healthy tissues, causing inflammation and damage in any organ such as the skin, joints, kidneys, heart, lungs, and brain.
The common symptoms include joint pains, rashes on the face and other sun exposed areas, hair fall, oral ulcers and fever. A characteristic feature is the malar rash — a butterfly-shaped rash across the cheeks and nose — which is one of the hallmark signs of lupus. Patients may experience periods of “flares”, where symptoms worsen, alternating with remission, when symptoms improve or disappear.
The exact cause although not fully understood, seems to be due to a combination of genetic predisposition, hormonal influences, smoking and environmental triggers such as infections or sunlight exposure.
Who gets lupus?
It predominantly affects women of child bearing age, typically between 15 and 45 years, although young kids and older adults are not spared. Male to Female ratio being 1:9. This gender difference is thought to be linked to hormones, particularly estrogen, which influences the immune system and may increase susceptibility to autoimmune diseases. This also has implications on issues like fertility, pregnancy, and long-term quality of life.
How is lupus diagnosed?
Lupus is diagnosed based on a combination of symptoms, physical examination, and blood tests. A key diagnostic marker is the anti-nuclear antibody (ANA) test, which is positive in the vast majority of lupus patients. A more specific marker is the anti-double stranded DNA (anti-dsDNA) antibody, which also helps monitor disease activity. If you have been told these tests are positive, it does not necessarily mean you have lupus — your doctor will consider all your symptoms and test results together before making a diagnosis.
Possible complications
Lupus is a “multi-system disease” meaning, it can affect nearly any organ in the body. Lupus complications may arise either from the disease itself or from long-term treatment. Some of the major complications include:
Kidney disease (lupus nephritis), which can lead to kidney failure. Read more about lupus nephritis here.
Cardiovascular disease, including heart attacks and strokes
Infections, due to immune dysfunction or immunosuppressive treatment
Joint damage and deformities
Bone problems, such as fractures or avascular necrosis
Eye complications, including cataracts and hydroxychloroquine-related retinopathy (damage to the retina from long-term use of hydroxychloroquine, requiring annual eye checks after 5 years of use)
Neurological disease leading to headaches, seizures, or cognitive dysfunction
Among these, cardiovascular disease is one of the leading causes of death in people with lupus.
How is quality of life affected?
Living with lupus can significantly impact a person’s quality of life. One of the most common lupus complications and challenging aspects is chronic fatigue, which can be severe and persistent even when other symptoms are controlled.
Pain, particularly joint and muscle pain, can limit physical activity. Frequent medical visits, medications, and the need for ongoing monitoring can also create emotional and financial strain.
The unpredictability of flares means that patients often have to adjust their daily routines, careers, and social lives. For example, avoiding sunlight (a known trigger for flares) may limit outdoor activities. Practical sun protection measures such as using broad-spectrum sunscreen (SPF 50 or higher), wearing protective clothing, and avoiding peak sun hours can help reduce flare risk.
Mental health can be affected too. Anxiety, depression, and feelings of isolation are not uncommon. However, with proper treatment and support, many people with lupus are able to lead active and fulfilling lives. Advances in management have significantly improved long-term outcomes.
How it affects reproduction in young women:
Because lupus primarily affects women in their reproductive years, its impact on fertility and pregnancy is particularly important.
Fertility: Fertility may be reduced in some cases. Factors such as disease activity, kidney involvement, and certain medications (like cyclophosphamide) can affect ovarian function.
Pregnancy risks: Pregnancy in lupus is considered high-risk, especially if the disease is active. Potential complications include:
Miscarriage (risk increases if there is an associated clotting disorder called anti phospholipid syndrome)
Preterm birth
Preeclampsia (high blood pressure in pregnancy)
Intrauterine growth restriction
Stillbirth
Certain antibodies (like SSA/SSB) can also lead to neonatal lupus or congenital heart block in the baby.
Disease activity and timing:The best outcomes occur when lupus is well-controlled for at least 6 months before conception.
Monitoring and care: Pregnancy in lupus requires close monitoring by a team including a rheumatologist and an obstetrician. With careful planning and management, many women with lupus can have successful pregnancies.
How is lupus treated?
There is currently no cure for lupus, but the disease is very treatable and most patients can achieve good control of their symptoms. Treatment is tailored to each individual depending on the organs involved and disease severity. The main treatment options for lupus complications include:
Hydroxychloroquine (Plaquenil) — a cornerstone medication for nearly all lupus patients. It reduces flares, controls symptoms, and has been shown to improve long-term survival. Regular eye check-ups are recommended for patients on long-term hydroxychloroquine.
Corticosteroids (e.g., prednisolone) — used to rapidly suppress inflammation during flares. Doctors aim to use the lowest effective dose for the shortest time possible to minimise side effects with long-term use.
Immunosuppressants (e.g., azathioprine, mycophenolate mofetil) — used for more severe or organ-threatening disease to reduce immune system overactivity. Cyclophosphamide may be used in serious cases such as severe kidney involvement.
Biologics (e.g., belimumab / Benlysta) — a newer class of targeted therapy that has been specifically approved for lupus. These treatments work by blocking specific parts of the immune system involved in lupus activity and are particularly useful for patients whose disease is difficult to control with conventional medications.
Good news
Despite its challenges, there is a lot of encouraging news about lupus today.
Awareness of lupus has increased, leading to earlier diagnosis and better patient support systems. Treatment options continue to evolve. Modern therapies can effectively control inflammation, reduce flares, and prevent organ damage. Survival rates have improved dramatically over the past few decades.
Finally, ongoing research is exploring new therapies, including targeted immunological treatments, which offer hope for even better outcomes in the future.
Perhaps most importantly, lupus is no longer seen as a condition that prevents people from living meaningful lives. With the right care, education, and support, individuals with lupus can pursue education, careers, relationships, and parenthood.
Conclusion
Lupus is a complex autoimmune disease that primarily affects young women and can involve multiple organs. While it poses challenges such as chronic symptoms, complications, and reproductive concerns, advances in medicine have transformed its outlook. Understanding the disease, recognizing its impact, and focusing on early and consistent care improves outcomes. Lupus is serious, but it is manageable and increasingly, it is a condition people can live well with.
About author
Dr. Chethana D is a senior rheumatologist at Aster CMI Hospital. She has rich experience in managing all rheumatological conditions including rheumatoid arthritis, psoriatic, reactive, crystal arthritis, osteoarthritis, ankylosing spondylitis, vasculitis like Wegener's granulomatosis, microscopic polyangiitis, Takayasu's arteritis, SLE, systemic sclerosis, myositis, sarcoidosis and chronic pain.
Comments